At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09939 KINTOR PHARMA-B
Market Closed 10-30 16:08:06
1.350
-0.090
-6.25%
High1.400
Low1.320
Vol797.50K
Open1.385
D1 Closing1.440
Amplitude5.56%
Mkt Cap673.65M
Tradable Cap673.65M
Total Shares499.00M
T/O1.09M
T/O Rate0.16%
Tradable Shares499.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
GenFleet-B Spends Around HK$12.9713 Million to Repurchase 560,000 Shares on October 30
Hong Kong Stock Movement: Alebund-B (09637) Surges Over 10% in Early Trading as Partner R1 Presents AP306 Global Phase IIb Multi-Regional Clinical Trial Design Poster at ASN Kidney Week
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.